Taika formulates ready-to-drink coffee beverages that combine coffee with natural stimulants and adaptogens such as L-theanine, ashwagandha and functional mushrooms (cordyceps, reishi, lion’s mane). Its current lineup includes a black coffee, an oat milk latte and a macadamia nut latte sweetened with allulose. The founders iterate via direct beta testing and customer feedback, calling the approach “stealth health” to deliver steady stimulation without noticeable side effects. The company has sold roughly 50,000 cans and distributes through stores across San Francisco and select Erewhon locations in Los Angeles. Taika has pursued retail, micro-kitchen deliveries and corporate office drops as early go-to-market channels. The team stresses science-backed, GRAS (generally recognized as safe) ingredients and continuous formulation tweaks as it scales.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

May 2020